Mike Ouimette - Jan 25, 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
General Counsel & Corp. Sec'y
Signature
/s/ Mike Ouimette
Stock symbol
PLRX
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 06:15 PM
Previous filing
Jan 25, 2023
Next filing
Mar 31, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Award $0 +39K +655.79% $0.00 44.9K Jan 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Award $0 +55K $0.00 55K Jan 25, 2023 Common Stock 55K $34.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units that vest in three equal annual installments beginning January 16, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.